NCT02244372

Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

A 8-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Accepted

Summary

The investigators performed randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Cordyceps sinensis mycelium culture extract (Paecilomyces hepiali, CBG-CS-2) on promotion of immunity. The investigators measured promotion of immunity parameters , including Cytotoxicity, Cytokine (IL-4, IL-6, IL-12, IFN-γ, TNF-α), hs-CRP, antibody titer, and upper respiratory tract infection(URI)

Conditions

• Immunity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Cordyceps sinensis mycelium culture extract 0.76 g
DIETARY_SUPPLEMENT	Cordyceps sinensis mycelium culture extract 1.15 g
DIETARY_SUPPLEMENT	Placebo

Timeline

• Start date: 2014-09-01
• Primary completion: 2014-09-01
• Completion: 2015-02-01
• First posted: 2014-09-19
• Last updated: 2019-08-22

Locations

1 site across 1 country: South Korea